<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Regen Biopharma Inc — News on 6ix</title>
<link>https://6ix.com/company/regen-biopharma-inc</link>
<description>Latest news and press releases for Regen Biopharma Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 20 Jan 2026 12:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/regen-biopharma-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835b76978dffbe2df11485d.webp</url>
<title>Regen Biopharma Inc</title>
<link>https://6ix.com/company/regen-biopharma-inc</link>
</image>
<item>
<title>Presenting on Emerging Growth Conference 89 Day 1 on January 21; Register to live stream</title>
<link>https://6ix.com/company/regen-biopharma-inc/news/presenting-emerging-growth-conference-89-120000751</link>
<guid isPermaLink="true">https://6ix.com/company/regen-biopharma-inc/news/presenting-emerging-growth-conference-89-120000751</guid>
<pubDate>Tue, 20 Jan 2026 12:00:00 GMT</pubDate>
<description>MIAMI, Jan. 20, 2026 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 89th Emerging Growth Conference on January 21 & 22, 2026. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting comp</description>
</item>
<item>
<title>Presenting on Emerging Growth Conference 88 Day 1 on December 10; Register to live stream</title>
<link>https://6ix.com/company/regen-biopharma-inc/news/presenting-emerging-growth-conference-88-120000414</link>
<guid isPermaLink="true">https://6ix.com/company/regen-biopharma-inc/news/presenting-emerging-growth-conference-88-120000414</guid>
<pubDate>Tue, 09 Dec 2025 12:00:00 GMT</pubDate>
<description>MIAMI, Dec. 09, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 88th Emerging Growth Conference on December 10 & 11, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting com</description>
</item>
<item>
<title>Goldman Small Cap Research Publishes New Research Report on Regen BioPharma, Inc.</title>
<link>https://6ix.com/company/regen-biopharma-inc/news/goldman-small-cap-research-publishes-new-research-report-on-regen-biopharma-inc</link>
<guid isPermaLink="true">https://6ix.com/company/regen-biopharma-inc/news/goldman-small-cap-research-publishes-new-research-report-on-regen-biopharma-inc</guid>
<pubDate>Wed, 05 Nov 2025 14:40:00 GMT</pubDate>
<description>Goldman Small Cap Research Publishes New Research Report on Regen BioPharma, Inc..</description>
</item>
<item>
<title>Presenting on Emerging Growth Conference 87 Day 2 on October 23; Register to live stream</title>
<link>https://6ix.com/company/regen-biopharma-inc/news/presenting-emerging-growth-conference-87-110000009</link>
<guid isPermaLink="true">https://6ix.com/company/regen-biopharma-inc/news/presenting-emerging-growth-conference-87-110000009</guid>
<pubDate>Wed, 22 Oct 2025 11:00:00 GMT</pubDate>
<description>MIAMI, Oct. 22, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 87th Emerging Growth Conference on October 22 & 23, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting comp</description>
</item>
<item>
<title>Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025</title>
<link>https://6ix.com/company/regen-biopharma-inc/news/regen-biopharma-update-on-orphan-drug-application-for-hemaxellerate-will-be-presented-at-emerging-growth-conference-on-september-24-2025</link>
<guid isPermaLink="true">https://6ix.com/company/regen-biopharma-inc/news/regen-biopharma-update-on-orphan-drug-application-for-hemaxellerate-will-be-presented-at-emerging-growth-conference-on-september-24-2025</guid>
<pubDate>Tue, 23 Sep 2025 12:00:00 GMT</pubDate>
<description>Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025.</description>
</item>
<item>
<title>Presenting on Emerging Growth Conference 86 Day 1 on September 24; Register to live stream</title>
<link>https://6ix.com/company/regen-biopharma-inc/news/presenting-emerging-growth-conference-86-110000894-1</link>
<guid isPermaLink="true">https://6ix.com/company/regen-biopharma-inc/news/presenting-emerging-growth-conference-86-110000894-1</guid>
<pubDate>Tue, 23 Sep 2025 11:00:00 GMT</pubDate>
<description>MIAMI, Sept. 23, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 86th Emerging Growth Conference on September 24 & 25, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting c</description>
</item>
<item>
<title>Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate</title>
<link>https://6ix.com/company/regen-biopharma-inc/news/regen-biopharma-prepares-response-for-fda-regarding-its-orphan-drug-application-for-hemaxellerate</link>
<guid isPermaLink="true">https://6ix.com/company/regen-biopharma-inc/news/regen-biopharma-prepares-response-for-fda-regarding-its-orphan-drug-application-for-hemaxellerate</guid>
<pubDate>Tue, 16 Sep 2025 12:00:00 GMT</pubDate>
<description>Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate.</description>
</item>
<item>
<title>Regen BioPharma Explores Expanded Use of HemaXellerate for Chemotherapy-Induced Bone Marrow Suppression</title>
<link>https://6ix.com/company/regen-biopharma-inc/news/regen-biopharma-explores-expanded-use-of-hemaxellerate-for-chemotherapy-induced-bone-marrow-suppression</link>
<guid isPermaLink="true">https://6ix.com/company/regen-biopharma-inc/news/regen-biopharma-explores-expanded-use-of-hemaxellerate-for-chemotherapy-induced-bone-marrow-suppression</guid>
<pubDate>Thu, 04 Sep 2025 12:00:00 GMT</pubDate>
<description>Regen BioPharma Explores Expanded Use of HemaXellerate for Chemotherapy-Induced Bone Marrow Suppression.</description>
</item>
<item>
<title>Presenting on Emerging Growth Conference 85 Day 1 on August 20; Register to live stream</title>
<link>https://6ix.com/company/regen-biopharma-inc/news/presenting-emerging-growth-conference-85-110000586-1</link>
<guid isPermaLink="true">https://6ix.com/company/regen-biopharma-inc/news/presenting-emerging-growth-conference-85-110000586-1</guid>
<pubDate>Tue, 19 Aug 2025 11:00:00 GMT</pubDate>
<description>MIAMI, Aug. 19, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 85th Emerging Growth Conference on August 20 & 21, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting compa</description>
</item>
<item>
<title>Regen BioPharma Discusses Potential Impact of HemaXellerate on Chemotherapy Treament Market</title>
<link>https://6ix.com/company/regen-biopharma-inc/news/regen-biopharma-discusses-potential-impact-of-hemaxellerate-on-chemotherapy-treament-market</link>
<guid isPermaLink="true">https://6ix.com/company/regen-biopharma-inc/news/regen-biopharma-discusses-potential-impact-of-hemaxellerate-on-chemotherapy-treament-market</guid>
<pubDate>Fri, 15 Aug 2025 13:00:00 GMT</pubDate>
<description>Regen BioPharma Discusses Potential Impact of HemaXellerate on Chemotherapy Treament Market.</description>
</item>
<item>
<title>Regen BioPharma, Inc. to Seek Orphan Drug Designation for Lead Product</title>
<link>https://6ix.com/company/regen-biopharma-inc/news/regen-biopharma-inc-to-seek-orphan-drug-designation-for-lead-product</link>
<guid isPermaLink="true">https://6ix.com/company/regen-biopharma-inc/news/regen-biopharma-inc-to-seek-orphan-drug-designation-for-lead-product</guid>
<pubDate>Wed, 23 Jul 2025 12:00:00 GMT</pubDate>
<description>Regen BioPharma, Inc. to Seek Orphan Drug Designation for Lead Product.</description>
</item>
<item>
<title>Presenting on Emerging Growth Conference 83 Day 2 on June 18; Register to live stream</title>
<link>https://6ix.com/company/regen-biopharma-inc/news/presenting-emerging-growth-conference-83-110000236-1</link>
<guid isPermaLink="true">https://6ix.com/company/regen-biopharma-inc/news/presenting-emerging-growth-conference-83-110000236-1</guid>
<pubDate>Tue, 17 Jun 2025 11:00:00 GMT</pubDate>
<description>MIAMI, June 17, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 83rd Emerging Growth Conference on June 17 & 18, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting compani</description>
</item>
<item>
<title>Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream</title>
<link>https://6ix.com/company/regen-biopharma-inc/news/presenting-emerging-growth-conference-82-110000524</link>
<guid isPermaLink="true">https://6ix.com/company/regen-biopharma-inc/news/presenting-emerging-growth-conference-82-110000524</guid>
<pubDate>Wed, 21 May 2025 11:00:00 GMT</pubDate>
<description>MIAMI, May 21, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 82nd Emerging Growth Conference on May 21 & 22, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies</description>
</item>
<item>
<title>Presenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live stream</title>
<link>https://6ix.com/company/regen-biopharma-inc/news/presenting-on-emerging-growth-conference-81-day-2-on-april-17-register-to-live-stream</link>
<guid isPermaLink="true">https://6ix.com/company/regen-biopharma-inc/news/presenting-on-emerging-growth-conference-81-day-2-on-april-17-register-to-live-stream</guid>
<pubDate>Wed, 16 Apr 2025 11:01:22 GMT</pubDate>
<description>Presenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live stream.</description>
</item>
<item>
<title>Presenting on the Emerging Growth Conference 80 Day 2 on March 27 Register Now</title>
<link>https://6ix.com/company/regen-biopharma-inc/news/presenting-on-the-emerging-growth-conference-80-day-2-on-march-27-register-now</link>
<guid isPermaLink="true">https://6ix.com/company/regen-biopharma-inc/news/presenting-on-the-emerging-growth-conference-80-day-2-on-march-27-register-now</guid>
<pubDate>Wed, 26 Mar 2025 11:00:23 GMT</pubDate>
<description>Presenting on the Emerging Growth Conference 80 Day 2 on March 27 Register Now.</description>
</item>
<item>
<title>Presenting on the Emerging Growth Conference 79 Day 1 on February 18 Register Now</title>
<link>https://6ix.com/company/regen-biopharma-inc/news/presenting-on-the-emerging-growth-conference-79-day-1-on-february-18-register-now-1</link>
<guid isPermaLink="true">https://6ix.com/company/regen-biopharma-inc/news/presenting-on-the-emerging-growth-conference-79-day-1-on-february-18-register-now-1</guid>
<pubDate>Tue, 18 Feb 2025 12:01:56 GMT</pubDate>
<description>Presenting on the Emerging Growth Conference 79 Day 1 on February 18 Register Now.</description>
</item>
<item>
<title>Regen BioPharma, Inc. Responds to Fake News Release</title>
<link>https://6ix.com/company/regen-biopharma-inc/news/regen-biopharma-inc-responds-to-fake-news-release</link>
<guid isPermaLink="true">https://6ix.com/company/regen-biopharma-inc/news/regen-biopharma-inc-responds-to-fake-news-release</guid>
<pubDate>Wed, 08 May 2019 22:59:13 GMT</pubDate>
<description>Regen BioPharma, Inc. Responds to Fake News Release.</description>
</item>
<item>
<title>Regen BioPharma, Inc. Examines Combining Cannabidiol (CBD) With Its Lead NR2F6 Agonist To Treat for Inflammatory Bowel Disease</title>
<link>https://6ix.com/company/regen-biopharma-inc/news/regen-biopharma-inc-examines-combining-cannabidiol-cbd-with-its-lead-nr2f6-agonist-to-treat-for-inflammatory-bowel-disease</link>
<guid isPermaLink="true">https://6ix.com/company/regen-biopharma-inc/news/regen-biopharma-inc-examines-combining-cannabidiol-cbd-with-its-lead-nr2f6-agonist-to-treat-for-inflammatory-bowel-disease</guid>
<pubDate>Tue, 08 Jan 2019 13:33:17 GMT</pubDate>
<description>Regen BioPharma, Inc. Examines Combining Cannabidiol (CBD) With Its Lead NR2F6 Agonist To Treat for Inflammatory Bowel Disease.</description>
</item>
<item>
<title>Regen BioPharma, Inc. Reports Additional New NR2F6 Small Molecule Inhibitors</title>
<link>https://6ix.com/company/regen-biopharma-inc/news/regen-biopharma-inc-reports-additional-new-nr2f6-small-molecule-inhibitors</link>
<guid isPermaLink="true">https://6ix.com/company/regen-biopharma-inc/news/regen-biopharma-inc-reports-additional-new-nr2f6-small-molecule-inhibitors</guid>
<pubDate>Tue, 13 Nov 2018 18:31:44 GMT</pubDate>
<description>Regen BioPharma, Inc. Reports Additional New NR2F6 Small Molecule Inhibitors.</description>
</item>
<item>
<title>Regen BioPharma, Inc. Determines Its Lead NR2F6 Agonist Ready for Inflammatory Bowel Disease Animal Studies</title>
<link>https://6ix.com/company/regen-biopharma-inc/news/regen-biopharma-inc-determines-its-lead-nr2f6-agonist-ready-for-inflammatory-bowel-disease-animal-studies</link>
<guid isPermaLink="true">https://6ix.com/company/regen-biopharma-inc/news/regen-biopharma-inc-determines-its-lead-nr2f6-agonist-ready-for-inflammatory-bowel-disease-animal-studies</guid>
<pubDate>Thu, 04 Oct 2018 20:07:14 GMT</pubDate>
<description>Regen BioPharma, Inc. Determines Its Lead NR2F6 Agonist Ready for Inflammatory Bowel Disease Animal Studies.</description>
</item>
</channel>
</rss>